Identification of epitopes that are recognized by diabetogenic T cells and cause selective beta cell destruction in type 1 diabetes (T1D) has focused on peptides originating from native beta cell proteins. Translational errors represent a major potential source of antigenic peptides to which central immune tolerance is lacking 1, 2 . Here, we describe an alternative open reading frame within human insulin mRNA encoding a highly immunogenic polypeptide that is targeted by T cells in T1D patients. We show that cytotoxic T cells directed against the N-terminal peptide of this nonconventional product are present in the circulation of individuals diagnosed with T1D, and we provide direct evidence that such CD8 + T cells are capable of killing human beta cells and thereby may be diabetogenic. This study reveals a new source of nonconventional polypeptides that act as self-epitopes in clinical autoimmune disease.
Islet-reactive CD8 + T cells selectively and progressively destroy the insulin-producing beta cells in type 1 diabetes (T1D) [3] [4] [5] [6] . Metabolic or inflammatory stress in the vicinity of the beta cells may contribute to the generation of neoantigens to which central immune tolerance is absent, thereby triggering autoimmunity 7, 8 . For example, larger numbers of splicing events are detected in human beta cells maintained in vitro in the presence of proinflammatory cytokines, mimicking the pathophysiological conditions of T1D 9, 10 . In addition, CD4 + T cells that recognize deamidated autoantigens [11] [12] [13] or fusion epitopes 14 have been detected in individuals with T1D. Inflammatory stress may perturb the cellular equilibrium and affect high-fidelity transcriptional and translational processes during conversion of the genetic information into proteins 15, 16 . In tumors, uncontrolled cell proliferation correlates with enhanced translation and accumulation of aberrant translation products. Such so-called defective ribosomal products (DRiPs) [17] [18] [19] , arising from the translation of normally untranslated regions (UTR), ribosomal frame-shifting or alternative initiation of translation, generate a unique class of tumor-associated antigens that are selectively expressed by malignant cells 20, 21 .
Human pancreatic beta cells are insulin factories dedicated to the maintenance of glucose homeostasis; insulin, stored in secretory granules, represents 10-15% of the protein content of these cells 22, 23 . Upon glucose challenge, insulin molecules are released into the circulation by exocytosis, and insulin mRNA is rapidly translated by polysomes to increase insulin biosynthesis. Studies of samples from humans with T1D and mouse models of the disease indicate that native insulin and its precursors act as primary autoantigens [24] [25] [26] , and fragments of the signal peptide of the preproinsulin (PPI) were identified as main targets of cytotoxic islet-autoreactive CD8 + T cells in human T1D 27 . In a process similar to the emergence of DRiPs during tumor development, the high demand for insulin may lead to the generation of aberrant insulin polypeptides by impaired translation fidelity, rendering beta cells immunogenic. These errors may yield antigens that trigger or accelerate islet autoimmunity in T1D, particularly as a result of stresses that, for example, may be evoked by viral infection 28 , reduced pancreas size 29 or inflammation 30 . Here, we investigated whether beta cells produce aberrant translation products that can lead to the generation of diabetogenic epitopes.
Leaky ribosome scanning for translation initiation at a downstream AUG can generate out-of-frame translation products 31 . Within the human insulin mRNA, two putative downstream translation initiation sites with strong Kozak consensus sequences are located at positions 72 and 341. Although translation initiation on the AUG at position 72 (which is in frame with the canonical AUG of PPI) would produce a truncated isoform of PPI, initiation on the AUG at position 341 would generate an alternative polypeptide in a +2 reading frame that does not share any sequence identity with the canonical translation product of the insulin gene (Fig. 1a,b) . The absence of a stop codon in this frame would lead to translation into the poly(A) tail. To validate that translation initiation can occur at this particular AUG, green fluorescent protein (GFP) fusion constructs were generated, in which the GFP coding sequence was fused in frame with the bona fide PPI AUG 60 (insulin (INS)-GFP) or with the alternative AUG at position 341 (INS-DRiP-GFP). As a control, a third construct was generated, in which the alternative reading frame was cloned immediately after the CMV promoter (DRiP-GFP) (Fig. 2a) . Following transfection in HEK 293T cells, in order to achieve high protein expression, both INS-GFP and INS-DRiP-GFP constructs led to expression of GFP fusion proteins migrating at 40 kDa and 33 kDa, respectively. The control construct, DRiP-GFP, confirmed the molecular weight of the unconventional product (Fig. 2b) . As expected, cells transfected with INS-DRiP-GFP also coexpress proinsulin as assessed by western blot (Fig. 2c) and immunohistochemistry (Fig. 2d) .
To determine the effect of endoplasmic reticulum stress (ER stress) on translation initiation, cells transfected with INS-DRiP-GFP were stimulated with the ER stress-inducers thapsigargin (TG) or tunicamycin (TM). The expression of DRiP polypeptide was increased by TG but not TM treatment as quantified both by western blot (Fig. 2e,  upper) and flow cytometry analysis (Fig. 2e, lower) . Altogether, these data indicate that the production of the INS-DRiP polypeptide may result from calcium depletion in the ER and the subsequent increase in levels of cytoplasmic calcium, rather than the classical ER stress caused by accumulation of misfolded proteins as induced by N-linked glycosylation inhibition (TM) 32 .
On the basis of the insulin sequence, translation of this neopolypeptide continues beyond the original PPI stop codon and leads to translation of two single nucleotide polymorphisms (SNPs) (rs3842752 and rs3842753) that are in strong linkage disequilibrium and are associated with development of T1D 33 . Although these SNPs have been judged to be functionally irrelevant because of their location within the INS 3′ UTR 34 , in this scenario, the SNPs rs3842752 and rs3842753 may generate four different polypeptide variants of the INS-DRiP polypeptide containing, respectively, cysteine-to-arginine (C-to-R) and histidine-to-proline (H-to-P) substitutions that may act as neoantigens in T1D (Fig. 3a) . To test the immunogenicity of the INS-DRiP variants, T cell proliferation assays were performed on freshly isolated peripheral blood mononuclear cells (PBMCs) of juveniles with T1D for detection of islet autoimmunity (Supplementary Table 1 and Fig. 3b) . Proliferative responses were detected in the majority of T1D cases that strongly correlated in reactivity between the 'susceptible' (R-P) and 'protective' (C-H) INS-DRiP variant, suggesting that the SNP region itself did not contribute to immunogenicity and underscoring the lack of presentation of the SNP by HLA-DQ (Fig. 3b, left) . Intriguingly, the few individuals carrying genetic risk variants associated with protection from T1D (HLA-DQ6.2 or INS SNP C-H) did not respond to INS-DRiP polypeptides, supporting the hypothesis that DQ6.2 and INS SNP C-H contribute to central immune tolerance in thymic education (Fig. 3b, right) . Strong T cell responses to INS-DRiP were detected in individuals with increased genetic risk for T1D (those heterozygous for HLA-DQ2 and HLA-DQ8 (HLA-DQ2/8); i.e., HLA-DQ8trans (formed by the α-chain of HLA-DQ2 (DQA1*05:01) and the β-chain of HLA-DQ8 (DQB1*03:02)) or HLA-DQ2trans (formed by the α-chain of HLA-DQ8 (DQA1*03:01) and the β-chain of HLA-DQ2 (DQB1*02:01)) (Fig. 3c) . Of note, the T cell response to INS-DRIP was similar in amplitude in comparison to the other known antigen targets in T1D (Supplementary Fig. 1a-c) .
Next, we interrogated whether dendritic cells (DC), which are uniquely capable of priming the immune system, were able to process and present peptides from the INS-DRiP polypeptide. Monocytederived, immature DC generated from DQ2-or DQ8-homozygous or DQ2/8-heterozygous donors were pulsed with the INS-DRiP variants. After 24 h of culture, the DC HLA-DQ ligandome was determined by mass spectrometry, revealing a short peptide fragment of 9 amino acids from the N-terminus of the INS-DRiP polypeptide as a single candidate epitope. A full overlap of the experimental fragmentation profile of the identified peptide and its synthetic counterpart confirmed proper MS identification (Fig. 3d) . Cell-free HLA-DQ binding studies confirmed a strong binding affinity of the 9-mer peptide to HLA-DQ8cis and HLA-DQ8trans molecules but not to HLA-DQ2cis or HLA-DQ2trans molecules (Fig. 3e) . The INS-DRiP polypeptide was screened for potential human leukocyte antigen (HLA)-class-I-binding epitopes. The INS-DRiP sequence was analyzed by three major histocompatibility complex (MHC) class I epitope prediction algorithms: NetMHC 3.4, SYFPEITHI and BIMAS. One strong HLA-A2-binding peptide was identified that was identical to the INS-DRiP 1-9 eluted from HLADQ8trans (Supplementary Table 2a) . The INS-DRiP 1-9 epitope MLYQHLLPL was confirmed to bind with high affinity to HLA-A2, which is the most prevalent HLA variant within the T1D population (Supplementary Table 2b and Supplementary Materials) 35, 36 .
We next assessed the clinical relevance of the INS-DRiP 1-9 epitope by exploring the presence of specific CD8 + T cells in peripheral blood samples from HLA-A2 + individuals with T1D and in HLA-and age-matched, healthy donors (detailed in Supplementary Table 3) 37 . Significantly higher levels of INS-DRiP 1-9 -specific CD8 + T cells were detected in individuals with T1D as compared to healthy donors, whereas antiviral CD8 + T cell frequencies were similar between the two groups (Fig. 4a) . Phenotypical analysis of INS-DRiP 1-9 -Tm + CD8 + T cells showed more cells with the effector phenotype (CCR7 − CD45RA − ) in donors with T1D than in healthy donors (Supplementary Fig. 2 ).
To further characterize these T cells, INS-DRiP 1-9 -specific T cell clones were generated from PBMCs of individuals with T1D by dual HLA tetramer staining, and their cytotoxic properties were determined on peptide-loaded HLA-A2 + JY cells (Fig. 4b,c and Supplementary  Fig. 3 ). Of note, these DRiP-specific CTL clones were generated from an individual with long-term diabetes (clone #1) as well as an individual with new-onset diabetes (clone #2); this indicates that such T cells are participating at different stages of disease progression. Complete lysis of peptide-pulsed target cells was detected, whereas target cells loaded with an irrelevant peptide remained unaffected (Fig. 4c) . Peptide-specific T cell activation resulted in a significant increase in the secretion of IFN-γ and tumor necrosis factor (TNF)-α-and, to a lesser extent, of macrophage inflammatory protein (MIP)-1β-when compared to unstimulated T cells (Fig. 4d) . We next examined the cytotoxic potential of the INS-DRiP 1-9 -specific CTL on human islet cells expressing HLA-A2. In order to specifically investigate beta cell death, dispersed primary human islets were transduced by a lentivirus containing the beta-cell-specific viability reporter (i.e., a short-half-life luciferase reporter gene under the control of the human insulin promoter, HIP-LUC2CP) as previously described 38 . Following LV-HIP-LUC2CP transduction, human pancreatic islet cells were incubated with CTLs specific for INS-DRiP 1-9 , CMVpp65 or PPI [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] , and cytolysis was determined by measuring reduction of luciferase activity. PPI 15-24 -specific and INS-DRiP 1-9 -specific CTLs significantly reduced beta cell survival (Fig. 4e, left) , whereas beta cell survival was unaffected by CMV-specific CTLs 38 . Together, beta cell destruction by the INS-DRiP 1-9 -directed CTLs confirmed that the DRiP 1-9 epitope is naturally generated, processed and presented on the cellular surface of human beta cells. The partial destruction of beta cells by INS-DRiP 1-9 -specific CTLs is in tune with the error hypothesis and points to beta cell heterogeneity and immunogenicity; this is perhaps due to differential sensitivity to stress factors. To test whether inflammation increases beta cell susceptibility to cytolysis by INS-DRiP 1-9 -specific T cells, beta cells were preconditioned with a medium containing high glucose in combination with the proinflammatory cytokines IL-1β and IFN-γ to mimic T1D pathology (Fig. 4e,  right) . As anticipated from our results regarding the effect of ER stress on DRiP translation (Fig. 2f) , these inflammatory conditions further increased beta cell death in the presence of INS-DRiP 1-9 -specific CTLs (Fig. 4f) . INS-DRiP 1-9 -specific CTL cocultured with human islets consistently secreted the effector cytokines MIP-1β, IFN-γ and TNF when recognizing the INS-DRiP epitope presented by HLA-A2, corroborating specific stimulation and activation of the CD8 + T cells by islets cells (Fig. 4g) .
We present the first evidence of a naturally processed and presented epitope derived from nonconventional islet proteins leading to the destruction of human beta cells by cytotoxic CD8 + T cells. We identified an immunogenic polypeptide translated from the insulin mRNA that is capable of triggering T cell proliferation in PBMCs from individuals with the highest odds ratio for T1D. In addition, we demonstrate that the epitope, presented by HLA-A2 as well as the highest-T1D-risk HLA-DQ8trans molecules expressed on DQ2/8 heterozygous DCs, is implicated in T1D pathogenesis as patientderived CTLs specific for this epitope are able to kill human beta cells in vitro. The presence of phenotypically naïve DRiP 1-9 -specific CTLs in healthy individuals and memory T cells in individuals with T1D indicates that neoantigen-specific CTLs are part of the normal T cell repertoire, and that the higher frequency and activated phenotype of these CTLs detected in PBMCs of individuals with T1D points to peripheral activation linking DRiP 1-9 -specific CTLs with the immunopathogenesis of T1D.
Our study proposes a new pathway of beta cell destruction by the immune system in which the generation of the neoepitope, such as INS-DRiP 1-9 , plays a central role. The mechanisms regulating the synthesis of the INS-DRiP polypeptide are still unknown, but two scenarios can be envisaged. In the first model, exon 2 of the insulin gene would be spliced from the pre-mRNA, thus positioning the AUG 341 as the first AUG encountered by the ribosome during scanning. Alternatively, the ribosome scan of the canonical AUG may result in translation initiation at a downstream AUG in the mature insulin mRNA. Since we could not detect such splicing variants in mRNA analysis of human pancreatic islets under either normal or pathogenic conditions (Supplementary Fig. 4) , we favor the alternative translation initiation as the most plausible mechanism. Although the results obtained on 293T cells should be interpreted with some caution, environmental modifications leading to ER stress appear to be an important component that can control expression of an alternative reading frame as described for other stress-induced proteins (i.e., ATF4 and ATF5) 39, 40 . The fact that human beta cells are exceptionally sensitive to ER stress reinforces this finding 41 . In addition to an effect on translation initiation processes, environmental stress may also have an impact on the degradation of insulin byproducts. The absence of an in-frame stop codon in the INS-DRiP protein is peculiar and may imply the participation of distinct elimination mechanisms that are engaged in clearing nonstop proteins 42, 43 . Yet, we cannot exclude the possibility that the increased beta cell death observed in pathophysiological condition results also from an increase in HLA-peptide complexes at the beta cell surface, similar to those seen in insulitic lesions found in the pancreases of individuals with type 1 diabetes 30 . Nevertheless, the implication of translational mistakes in autoimmunity begs for revision of transcriptome-based approaches for epitope discovery and offers alternatives for tissueand antigen-specific therapeutic approaches aiming at the induction of immune tolerance. Our findings further support the emerging concept that beta cells are destroyed in T1D by a mechanism comparable to classical antitumor responses whereby the immune system has been trained to survey for dysfunctional cells in which errors have accumulated 1 .
MeTHoDS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. Proteins and peptides. Human recombinant proteins GAD65, IA-2 and PPI were synthesized as previously described 46 . Recombinant INS-DRiP R-P and INS-DRiP C-H were obtained from human islet cDNA by PCR, consisting of the 43 amino acids encoded within the insulin mRNA excluding the poly(A) tail. These sequences were subsequently cloned into a bacterial expression vector Gateway cloning technology (Invitrogen, Carlsbad, CA, USA) creating an N-terminal histidine tag, used for protein purification on nickel column (GE Healthcare, #17531801). Peptides were synthesized by solid-phase Fmoc chemistry and validated by ultra-performance liquid chromatography and mass spectrometry. Peptides (purity > 85%) were dissolved in 5% DMSO/PBS to a 1 mM stock solution.
Peptide binding assay. HLA class II binding affinity of peptides was measured in a cell-free competitive peptide binding assay 47, 48 . Binding competition between an increasing amount peptide of interest (0-300 µM) and a fixed amount of biotinylated reporter peptide (0.6 µM) in HLA-DQ2 and HLA-DQ8 molecules isolated from transduced 293T cells was determined. After overnight incubation at 4 °C, plates were washed, and europium-streptavidin in assay buffer was added to each well followed by incubation while shaking. After washing, wells were incubated with enhancement buffer. Plates were read using a time-resolved fluorometer (1234, Wallac). IC 50 Generation and pulsing of human DCs. Monocytes were isolated from buffy coats of homozygous HLA-DQ2, homozygous HLA-DQ8 or heterozygous HLA-DQ2/8 donors using CD14 + Macs sorting (Miltenyi Biotec, #130050201), and monocyte-derived DCs were generated as described previously 49 . Briefly, peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll gradient and subsequently CD14 + monocytes were isolated and cultivated with GM-CSF (800 U/ml) and IL-4 (500 U/ml) (Invitrogen, Breda, the Netherlands) for 6 d to obtain immature DCs (iDCs). These iDCs (0.5 × 10 6 /well) were pulsed with recombinant INS-DRiP polypeptide (10 µg/mL) in the presence of lipopolysaccharide (100 ng/ml) and IFN-γ (1000 U/ml) to induce DC maturation. After 30 h, the pulsed and matured DCs were harvested, washed with PBS and lysed in 1 ml lysis buffer (50 mM Tris, 150mM NaCl, 5 mM EDTA, 0.5% Zwitterion, 10 mM iodoacetamide and a complete protease inhibitor mix (Roche Applied Science)). To remove nuclei and insoluble material the lysates were centrifuged for 60 min at 10,000 × g.
Peptide elution of HLA class II and mass spectrometry analysis. The HLA-DQ molecules were extracted from the DC lysates by affinity purification 50, 51 . Lysates were precleared with Sepharose beads and mixed with Sepharose beads coupled with a pan-DQ antibody (purified from SPV-L3 hybridoma). After 60 min of incubation the beads were washed with 5 bed volumes lysis buffer subsequently followed by 4 bed volumes of low salt buffer (120 mM NaCl, 20 mm Tris-HCl, pH 8.0), 8 bed volumes of high salt buffer (1 M NaCl, 20 mM TrisHCl, pH 8.0), 4 bed volumes of no salt buffer (20 mM Tris-HCl, pH 8.0), and 4 bed volumes of low Tris buffer (10 mM Tris-HCl, pH 8.0). The HLA-peptide complexes were eluted with 5 bed volumes of 10% acetic acid. The eluate was applied on a small homemade C18 column and eluted in two fractions with 20 and 30% acetonitrile. Subsequently, the HLA peptides were analyzed via on-line C18-nanoHPLC-MS with a system consisting of an Easy nLC 1000 gradient HPLC system (Thermo Scientific), and a Q Exactive mass spectrometer (Thermo Scientific). Fractions were injected onto a homemade precolumn (100 µm × 15 mm; ReproSil-Pur C18-AQ, 3 µm, Dr. Maisch, Ammerbuch, Germany) and eluted via a homemade analytical nano-HPLC column (15 cm × 50 µm; ReproSil-Pur C18-AQ, 3 µm). The gradient was run from 0 to 30% solvent B (10:90:0.1 water/acetonitrile/formic acid [v/v/v]) in 120 min. The nano-HPLC column was drawn to a tip of ~5 µm and acted as the electrospray needle of the MS source. The Q Exactive mass spectrometer was operated in top10 mode. Parameters were resolution 70,000 at an automatic gain control target value of 3 million maximum fill time of 100 ms (full scan), and resolution of 35,000 at an automatic gain control target value of 1 million/maximum fill time of 128 ms for MS/MS at an intensity threshold of 780,000. Apex trigger was set to 1-5 s, and allowed charges were 1-3. All fractions were measured twice. In a postanalysis process, raw data were converted to peak lists using Proteome Discoverer 1.4. For peptide identification, MS/MS spectra were submitted to the human IPI database supplemented with INS-DRiP amino acid sequence using Mascot Version 2.4 (Matrix Science) with the following settings: 10 ppm and 20 millimass units deviation for precursor and fragment masses, respectively; no enzyme was specified. All reported hits were assessed manually, and peptides with Mascot scores <35 were generally discarded.
Blood donors and genotyping. After informed consent, blood was collected from 46 new-onset T1D donors (Supplementary Table 1 ). PBMCs isolated from donors with celiac disease (CD) were used as an age-and HLA-DQ matched control cohort (n = 9). The genotype of the T1D blood donors was determined by PCR. PCR was performed in a total volume of 25 µl, using 50 ng of genomic DNA and 10 pmol of each primer. The amplification buffer consisted of 1× Flexi Buffer, 1.5 mM MgCl 2 , 200 µM dNTPs and 0.5 unit of Taq DNA polymerase (all reagents were obtained from Promega). PCR was carried out in a Peltier Thermal Cycler (PTC-200; MJ Research). After initial denaturation at 95 °C for 5 min, 35 cycles were run, consisting of denaturation at 94 °C for 30 s, annealing at 60 °C (rs3842752) or 65 °C (rs3842753) for 30 s and extension at 72 °C for 30 s. Finally, a 5 min extension step was performed at 72 °C. For visualization, 5 µl of the amplification products were run on a 2% agarose MP gel (Boehringer Mannheim) prestained with ethidium bromide.
Genotyping was assessed by PCR using a common forward primer (5′-TGGGGC AGGTGGAGCT-3′) and allele-specific revers primers. The presence of allele A or G in SNP rs3842752 was determined using 5′-(T/G)GGGGCTGCCTGCA-3′ or 5′-(T/G)GGGGCTGCCTGCG-3′, respectively. The presence of allele T or G in SNP rs3842753 has been determined using 5′-GAGGCGGCGGGTGT-3′ or 5′-GAGGCGGCGGGTGG-3′ reverse primers, respectively.
T cell proliferation assay. Freshly isolated PBMCs were used to investigate the immunogenicity of recombinant INS-DRiP polypeptide in a T cell proliferation assay 52 . PBMCs were seeded (150,000/well) in flat-bottomed 96-well microculture plates (Greiner, Nürtingen, Germany) and cultured for 5 days at 37 °C in 5% CO 2 , in a humidified atmosphere. Cells were cultured in triplicates in medium alone, with 10 µg/ml recombinant INS-DRiP polypeptide, or recombinant IL-2 10% (25 units/mL; Genzyme, Cambridge, MA) as positive control. In the final 16 h of culture, 50 µl RPMI 1640 (Dutch modification; Gibco) containing 0.5 µCi 3 H-thymidine (DuPont NEN, Boston, MA) was added per well. After the cells were harvested on filters with an automated harvester, proliferation was determined by the measurement of 3 H-thymidine incorporation in an automatic liquid scintillation counter. All results are calculated as mean counts per minute (CPM) in the presence of antigen and compared with medium alone.
Detection of epitope-specific CD8 + T cells in PBMCs of T1D patients.
Heparinized blood samples were drawn from 24 T1D patients (including new onset patients) and 13 sex-and age-matched healthy controls (Supplementary Table 2 ). Sample sizes were determined based on expected variation reported by previous studies 5 . PBMCs were isolated by Ficoll-isopaque density gradient centrifugation and frozen in liquid nitrogen until use. For the detection of epitope-specific CD8 + T cells, thawed PBMCs were stained with Qdotlabeled multimeric complexes. Peptide-HLA-A2 (pHLA-A2) monomers and multimeric pHLA-A2 complexes were generated as previously described 27 . Samples with CD8 + T cell counts under 50,000 were excluded from analysis.
